Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Colin G de Haar"'
Autor:
Maud Plantinga, Vania Lo Presti, Colin G. de Haar, Ester Dünnebach, Alejandro Madrigal, Caroline A. Lindemans, Jaap Jan Boelens, Stefan Nierkens
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Hematopoietic cell transplantation (HCT) is a last resort, potentially curative treatment option for pediatric patients with refractory acute myeloid leukemia (AML). Cord blood transplantation (CBT) results in less relapses and less graft-versus-host
Externí odkaz:
https://doaj.org/article/ae61d80aa4024b78b602ce6cc78c2473
Autor:
Maud Plantinga, Colin G. de Haar, Ester Dünnebach, Denise A. M. H. van den Beemt, Kitty W. M. Bloemenkamp, Michal Mokry, Jaap Jan Boelens, Stefan Nierkens
Publikováno v:
Cancers, Vol 11, Iss 2, p 181 (2019)
Dendritic cells (DCs) are professional antigen-presenting cells which instruct both the innate and adaptive immune systems. Once mature, they have the capacity to activate and prime naïve T cells for recognition and eradication of pathogens and tumo
Externí odkaz:
https://doaj.org/article/f1e51050e437422a8a98e4ac36be0057
Autor:
Lisanne M Baak, Nienke Wagenaar, Niek E van der Aa, Floris Groenendaal, Jeroen Dudink, Maria Luisa Tataranno, Ubah Mahamuud, Cornelia H Verhage, Rian M J C Eijsermans, Liesbeth S Smit, Reint K Jellema, Timo R de Haan, Hendrik J ter Horst, Willem P de Boode, Sylke J Steggerda, Henk-Jan Prins, Colin G de Haar, Linda S de Vries, Frank van Bel, Cobi J Heijnen, Cora H Nijboer, Manon J N L Benders
Publikováno v:
Lancet Neurology, 21, 528-536
The Lancet Neurology, 21(6), 528-536. ELSEVIER SCIENCE INC
The Lancet Neurology, 21(6), 528-536. Lancet Publishing Group
Lancet Neurology, 21, 6, pp. 528-536
Lancet Neurology, 21(6), 528-536. Elsevier Science
The Lancet Neurology, 21(6), 528-536. ELSEVIER SCIENCE INC
The Lancet Neurology, 21(6), 528-536. Lancet Publishing Group
Lancet Neurology, 21, 6, pp. 528-536
Lancet Neurology, 21(6), 528-536. Elsevier Science
Background: Perinatal arterial ischaemic stroke (PAIS) is an important cause of neurodevelopmental disabilities. In this first-in-human study, we aimed to assess the feasibility and safety of intranasally delivered bone marrow-derived allogeneic mese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3b9600b853c4dd6706bbfc8d3b71ca6
http://hdl.handle.net/2066/282263
http://hdl.handle.net/2066/282263